project, Dr. Charles Martel.â
âDr. Ibanez,â began Charles, âI . . .â
âJust a minute, Charles,â interrupted Ibanez. âLet me get rid of Jules here. Now you think youâve got all that, Jules?â
âDr. Ibanez,â Charles broke in. âI really want to say something.â
âIn a minute, Charles. Listen, Jules, I want you to make Charles here sound like Louis Pasteur reincarnated, understand?â
âYou got it,â said Bellman excitedly. âNow, Dr. Martel. Can you tell me your latest publications.â
âGoddammit,â shouted Charles, slamming his lab books down on Ibanezâs desk. âThis is a ridiculous conversation. You know I havenât published anything recently, mostly because I didnât want to take the time. But papers or no papers, Iâve been making extraordinary progress. And itâs all here in these books. Let me show you something.â
Charles reached over to open one of the lab books but Dr. Ibanez restrained his arm. âCharles, calm down. Youâre noton trial here, for Godâs sake. Actually itâs probably better you havenât published. Right now interest as well as funding for immunological cancer research has slackened. It probably wouldnât be good for Jules to have to admit youâve been working exclusively in this area because the press might suggest you were unqualified to take over Canceran.â
âGive me strength,â groaned Charles to himself through clenched teeth. He stared at Ibanez, breathing heavily. âLet me tell you something! The whole medical community is approaching cancer from the wrong perspective. All this work on chemotherapeutic agents like Canceran is only for palliative purposes. A real cure can only come from better understanding of the chemical communication among cells of which the immune system is a direct descendant. Immunology is the answer!â Charlesâs voice had built to a crescendo, and the last sentence held the fervor of a religious fanatic.
Bellman looked down and shuffled his feet. Ibanez took a long drag on his cigar, blowing the smoke in a long, thin stream.
âWell,â said Dr. Ibanez, breaking the embarrassing silence. âThatâs an interesting point, Charles, but Iâm afraid not everybody would agree with you. The fact of the matter is that while there is plenty of funding for chemotherapy research, there is very little for immunological studies . . .â
âThatâs because chemotherapy agents like Canceran can be patented whereas immunological processes, for the most part, cannot be,â said Charles, impulsively interrupting Dr. Ibanez.
âIt seems to me,â said Ibanez, âthat the old phrase, âdonât bite the hand that feeds you,â applies here. The cancer community has supported you, Dr. Martel.â
âAnd Iâm thankful,â said Charles. âIâm not a rebel or a revolutionary. Far from it. All I want is to be left alone to do my work. In fact, thatâs why I came up here in the first place: to tell you that I donât feel capable of taking on the Canceran project.â
âNonsense!â said Ibanez. âYouâre more than capable. Obviously the board of directors thinks so.â
âIâm not talking about my intellectual capabilities,â snapped Charles. âIâm talking about my lack of interest. I donât believe in Canceran and the approach to cancer it represents.â
âDr. Martel,â said Dr. Ibanez slowly, his eyes boring into Charlesâs face. âAre you aware that we are in the midst of a crisis? Are you going to sit there and tell me you cannot help because of a lack of interest? What do you think Iâm running here, a federally endowed college? If we lose the grant for Canceran the whole institute is in financial jeopardy. Youâre the only person who is not